PharmiWeb.com - Global Pharma News & Resources
14-Jun-2019

Neuroprotective Agents Market 2019 Global Size, Growth, Regions, Type and Application, Status Forecast by 2019-2024

Market Research Engine has published a new report titled asNeuroprotective Agents Market Size, By Drug (Cholinesterase inhibitors, NMDA Receptor Antagonists, Anti-inflammatory & Anti-apoptotic Agents, Neurotropic Factors, Mitochondrial Dysfunction Regulators, Metal Ion Chelators, Ion Channel Modulators, Free Radical Trappers, Anti-excitotoxic Agents), By Treatment (Alzheimer's Disease, Multiple Sclerosis, Parkinson's Disease, Ocular Degeneration (Retinal Disorders), Amyotrophic Lateral Sclerosis (ALS), Huntington's Disease, Neuropathies, Brain Injury), By Region, Market Analysis Report, Forecast 2019-2024.”

Report scope:

The scope of the report includes a detailed study of neuroprotective agents market with the reasons given for variations in the growth of the industry in certain regions.

The top company reports are intended to provide our buyers with a snapshot of the industry’s most influential players.

Rising prevalence of neurological disorders, especially neurodegenerative diseases is majorly enhancing the neuroprotective agents industry growth rate. Other contributing factors include rising average life spans, brain injuries due to road accidents, and traumatic & stroke central nervous system injuries will also boost the business growth.

Browse Full Report: https://www.marketresearchengine.com/neuroprotective-agents-market

The neuroprotective agents market is segmented on the lines of its drugs, treatment, and regional. The basis of drug the market is segmented into Cholinesterase inhibitors, NMDA Receptor Antagonists, Anti-inflammatory & Anti-apoptotic Agents, Neurotropic Factors, Mitochondrial Dysfunction Regulators, Metal Ion Chelators, Ion Channel Modulators, Free Radical Trappers, and Anti-excitotoxic Agents. Based on application the global neuroprotective agents market covers Alzheimer's Disease, Multiple Sclerosis, Parkinson's Disease, Ocular Degeneration (Retinal Disorders), Amyotrophic Lateral Sclerosis (ALS), Huntington's Disease, Neuropathies, and Brain Injury. The neuroprotective agents market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, and Rest of World. Each geographic market is further segmented to provide market revenue for selected countries such as the U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.

Lack of particular treatment alternatives will offer immense opportunities for the industry players to increase their presence in the marketplace. However, stringent regulatory approvals, high failure rate of prospective drugs in clinical trials and high costs involved in research activities may negatively affect the neuroprotective agents market size.

The report covers a detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include NeuroVive Pharmaceutical, Genervon Biopharmaceuticals, Allon therapeutics, Inc., BHR Pharma LLC, Ceregene, Neuren Pharmaceuticals, and Bionure Inc. Company profile includes assigning such as company overview, product landscape, financial overview, and recent developments.

Competitive Rivalry

NeuroVive Pharmaceutical, Genervon Biopharmaceuticals, Allon therapeutics, Inc., BHR Pharma LLC, Ceregene, Neuren Pharmaceuticals, and Bionure Inc are among the major players in the global neuroprotective agents market share. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.

The Neuroprotective Agents Market has been segmented as below:

Neuroprotective Agents Market, By Drugs

  • Cholinesterase inhibitors
  • NMDA receptor antagonists
  • Anti-inflammatory and anti-apoptotic agents
  • Neurotropic factors
  • Mitochondrial dysfunction regulators
  • Metal Ion Chelators
  • Ion channel modulators
  • Free radical trappers
  • Anti excitotoxic agents
  • Others

Neuroprotective Agents Market Research, By Treatment

  • Alzheimer's disease
  • Multiple sclerosis
  • Parkinson's disease
  • Ocular degeneration (retinal disorders)
  • Amyotrophic lateral sclerosis (ALS)
  • Huntington's disease
  • Neuropathies
  • Brain injury
  • Other disorders

Neuroprotective Agents Market, By Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of World

The report covers:

  • An overview of the global neuroprotective agents market and related technologies
  • Analyses of global market trends, with actual data for 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2024
  • Identifications of new market opportunities and targeted promotional plans for neuroprotective agents market
  • Discussion of research and development, and the demand for new products and new applications.
  • Comprehensive company profiles of major players in the industry.

Reasons to Buy this Report:

  • Obtain the most up to date information available on the neuroprotective agents market
  • Identify growth segments and opportunities in the industry
  • Facilitate decision making on the basis of strong historic and forecast for neuroprotective agents market
  • Assess your competitor’s refining portfolio and its evolution

Request Sample Report from here: https://www.marketresearchengine.com/neuroprotective-agents-market

Table of Contents:

  1.  Introduction
  2.  Research Methodology
  3.  Executive Summary
  4.  Market Overview
     4.1.    Introduction
        4.2.    Drivers
            4.2.1.    Increasing prevalence of neurological disorders
            4.2.2.    Longer life spans
        4.3.    Restraints
            4.3.1.    Insufficient clinical research
            4.3.2.    Stringent regulatory approval
        4.4.    Opportunities
            4.4.1.    Increasing R&D
        4.5.    Challenges
            4.5.1.    High costs involved in developing the product
            4.5.2.    High failure rate in clinical trials
  5.  Neuroprotective Agents Market, By Drugs
  6.  Neuroprotective Agents Market, By Treatment
  7.  Competitive Landscape
  8.  Company Profile
     8.1.    NeuroVive Pharmaceutical
            8.1.1.    Company Overview
            8.1.2.    Product/Service Landscape
            8.1.3.    Financial Overview
            8.1.4.    Recent Developments
        8.2.    Genervon Biopharmaceuticals
            8.2.1.    Company Overview
            8.2.2.    Product/Service Landscape
            8.2.3.    Financial Overview
            8.2.4.    Recent Developments
        8.3.    Allon therapeutics, Inc.
            8.3.1.    Company Overview
            8.3.2.    Product/Service Landscape
            8.3.3.    Financial Overview
            8.3.4.    Recent Developments
        8.4.    BHR Pharma LLC
            8.4.1.    Company Overview
            8.4.2.    Product/Service Landscape
            8.4.3.    Financial Overview
            8.4.4.    Recent Developments
        8.5.    Ceregene
            8.5.1.    Company Overview
            8.5.2.    Product/Service Landscape
            8.5.3.    Financial Overview
            8.5.4.    Recent Developments
        8.6.    Neuren Pharmaceuticals
            8.6.1.    Company Overview
            8.6.2.    Product/Service Landscape
            8.6.3.    Financial Overview
            8.6.4.    Recent Developments
        8.7.    Bionure Inc.
            8.7.1.    Company Overview
            8.7.2.    Product/Service Landscape
            8.7.3.    Financial Overview
            8.7.4.    Recent Developments

 

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay

Email: john@marketresearchengine.com

Phone: +1-855-984-1862

Country: United States

Website: https://www.marketresearchengine.com/

Editor Details

Related Links

Last Updated: 18-Jun-2019